Our team is led by a successful repeat founder who has brought together scientists, engineers and business development executives, guided by experts in oncology, neuroscience, AI, extracellular vesicles, microRNA, and microfluidics
in order to tackle a biomarker intelligence problem requiring a global collaboration amongst universities, providers, pharma, and payors.
